The store will not work correctly when cookies are disabled.
1-{3-[4-(tert-butyl) phenyl]-5-N,N-dimethylamino-(1,2,4-triazol-4-yl)}-3-phenol
ID: ALA377904
PubChem CID: 10308746
Max Phase: Preclinical
Molecular Formula: C20H24N4O
Molecular Weight: 336.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)c1nnc(-c2ccc(C(C)(C)C)cc2)n1-c1cccc(O)c1
Standard InChI: InChI=1S/C20H24N4O/c1-20(2,3)15-11-9-14(10-12-15)18-21-22-19(23(4)5)24(18)16-7-6-8-17(25)13-16/h6-13,25H,1-5H3
Standard InChI Key: XXDJNJPGLULDCJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
1.7260 -23.5792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3954 -23.0870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1324 -22.3008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3032 -22.3075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0528 -23.0979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1129 -23.4831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1279 -24.3090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8495 -24.7073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8155 -23.0571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7296 -24.4009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0162 -24.8176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0213 -25.6418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7391 -26.0504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4531 -25.6287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4445 -24.8059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5377 -23.4517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5557 -24.2774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1718 -26.0339 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2793 -24.6736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6875 -23.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8625 -25.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0007 -25.0738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2701 -23.3586 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3471 -22.8112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1046 -24.1669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 12 1 0
12 13 2 0
6 7 2 0
13 14 1 0
1 2 1 0
14 15 2 0
15 10 1 0
1 10 1 0
7 8 1 0
8 17 2 0
16 17 1 0
3 4 1 0
14 18 1 0
16 9 2 0
17 19 1 0
9 6 1 0
19 20 1 0
2 6 1 0
19 21 1 0
4 5 2 0
19 22 1 0
5 1 1 0
5 23 1 0
10 11 2 0
23 24 1 0
2 3 2 0
23 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.44 | Molecular Weight (Monoisotopic): 336.1950 | AlogP: 4.00 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.99 | CX Basic pKa: 2.31 | CX LogP: 4.83 | CX LogD: 4.83 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.79 | Np Likeness Score: -1.23 |
References
1. Zhang Q, Keenan SM, Peng Y, Nair AC, Yu SJ, Howells RD, Welsh WJ.. (2006) Discovery of novel triazole-based opioid receptor antagonists., 49 (14): [PMID:16821764] [10.1021/jm0601250] |